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Purpose: Venous malformations (VMs) may be discrete or extensive, and larger lesions 
may be difficult o remove with surgery. Incompletely removed lesions have a tendency to 
recur. We report our experience with ethanol ablation f VMs. 
Methods: All 12 patients (seven women; mean age, 37 years) were evaluated with magnetic 
resonance imaging before treatment. A total of 19 prior surgical excisions had been 
performed for seven of the patients. Symptoms were present in all 12 patients and 
included bleeding, pain, swelling, and limitation of exercise. The VMs were present in the 
lower extremities of seven patients, in the upper extremities of three patients, and in the 
flank and buttocks in two patients. 
Results: The 12 patients have undergone 30 injection procedures, with six patients 
requiring one, three patients requiring two, two patients requiring three, aud one patient 
having undergone 12 treatments. General anesthesia was used in 11 patients. Blood loss 
was minimal for all procedures, and 28 of the 30 procedures were technically successful. 
Skin ulceration was seen in approximately half of the treated VMs, all of which healed 
with local wotmd care. Focal VMs were injected in six patients and resolved with a single 
treatment in five patients. Patients were free of symptoms at a mean follow-up of 10 
months. Extensive VMs were injected for discrete, symptomatic areas in five patients. 
These lesions all regressed and were asymptomatic at a mean follow-up of 23 months in 
all but one patient. However, these lesions required muitiple treatments as additional 
areas became problematic. 
Conclusions: Ethanol sclerosis is a well-tolerated, safe, and effective adjunct to the 
management of VMs. Advantages of ethanol injection include the ability to treat a very 
localized area without an incision. Conversely, extensive lesions may be palliated as 
symptoms occur. (J Vasc Surg 1997;26:838-44.) 
Venous malformations (VMs) are a difficult entity 
to treat because they are often extensive and have a 
tendency to recur after treatment. These low-flow 
lesions are either capillary or venous malformations 
that are present at birth and grow with the patient. 
Although VMs can be limited to subcutaneous ti - 
sues, they often grow among muscles, nerves, and 
blood vessels, which makes them difficult o delineate 
from normal tissues radiologically. 1 Operative re- 
moval of extensive lesions may be difficult and is 
often accompanied by a large amount of blood loss. 
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Because these lesions are often symptomatic, 
various radiologic interventions have been used in 
their treatment. Arterial embolization of  the nidus 
via selective catheterization f the feeding vessels, 
although effective for high-flow arteriovenous mal- 
formations and fistulas, 2-9 usually only decreases 
the size of  VMs and does not obliterate the anom- 
alous channels, 1° and therefore should not be used 
in the treatment of  VMs. In contrast, direct punc- 
ture of the lesions with installation of  a sclerosing 
agent has been reported to be effective in treating 
VMs. 1,a,1°,11 Ethanol is an effective sclerosing 
agent and causes necrosis of vessel walls with 
sludging of  red blood cells and subsequent throm- 
bosis. This leads to the eventual production of 
intimal fibrosis related to ethanol's protein dena- 
turing and hydroscopic properties. 11,~2 We report 
our experience with direct injection of  absolute 
ethanol into a series of VMs to explore the selec- 
tion, techniques, complications, a d results with 
this treatment. 
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METHODS 
Patients who were treated at Northwestern Me- 
morial Hospital between the years of 1993 and 1996 
were eligible for the study. Patients were treated after 
appropriate informed consent was obtained. Data 
were collected from chart review, clinic visits, and 
telephone conversations. M1 12 patients (seven 
women; mean age, 37 years) were evaluated with 
magnetic resonance imaging (MILl) before treat- 
ment. Venograms and arteriograms were also per- 
formed for selected patients, and all arteriovenous 
malformations and fistulas were specifically excluded 
from this report. A total of 19 prior surgical exci- 
sions had been performed for seven of the patients. 
Symptoms were present in all 12 patients and in- 
cluded bleeding, pain, swelling, and limitation of 
exercise. The VMs were present in the lower extrem- 
ities of seven patients, in the upper extremities of 
three patients, and in the buttock and flank of two 
patients. Lesions were focal and circumscribed in 
seven patients and extensively involved the majority 
of an extremity in five patients. General anesthesia 
was used for all but one patient because of the ex- 
treme pain that follows ethanol injection. Contrast 
material was injected irectly into the lesion to deter- 
mine the extent of the VM and to estimate the 
amount of ethanol required to fill the VM in its 
dilated state without filling normal venous chan-  
nels. After defining the cavity size, absolute etha- 
nol was then injected irectly and contained within 
the VM using tourniquet, manual compression, or 
both for 15 to 20 minutes. Residual ethanol was 
successfully aspirated from some of the lesions, 
whereas other VMs contained only thrombosed 
blood. Contrast material was again injected to 
confirm the extent of  VM thrombosis, and further 
injections of  ethanol were used if a residual cavity 
was demonstrated by contrast injection. Great care 
was used in the positioning of the needle inside the 
lesion to prevent extravasation of ethanol, which 
can cause extensive tissue necrosis. Steroids were 
used during and after procedures to reduce inflam- 
mation, and selected patients were sent home on a 
Medrol Dose Pack (Upjohn, Kalamazoo, Mich.). 
Ketoralac was used for analgesia, and the proce- 
dure was usually performed on an outpatient or 
23-hour admission basis. 
Follow-up was measured from the time of treat- 
ment to the last contact with the patient at either 
repeat imaging studies, office visits, or telephone 
conversations. In the event of multiple treatments, 
follow-up was measured from the time of the first 
injection. 
RESULTS 
A listing of the individual patients and their treat- 
ment is provided in Table I. The 12 patients have 
undergone 30 injection procedures, with six patients 
requiring one treatment, three patients requiring two 
treatments, two patients requiring three treatments, 
and one patient having undergone 12 treatments. 
The amount of ethanol injected into the lesions 
ranged from 0.8 to 40 ml, with a mean of 9 ml per 
session. The estimated blood loss was minimal for all 
procedures, and 28 of the 30 procedures were tech- 
nically successful. One procedure arly in this series 
was aborted because of an inability to place the nee- 
dle into the lesion without extravasation f contrast 
material. This 2 × 3 cm lesion was surgically excised 
with a good result. Another patient underwent two 
successful treatments but still had residual VM that 
could not be accessed on the third treatment. Extrav- 
asation of ethanol was not observed in the 28 suc- 
cessfully performed procedures. Skin ulceration was 
produced in approximately h~df of the treated VMs, 
all of which healed with local wound care that con- 
sisted of outpatient debridement and saline wet to 
dry dressing changes. All wounds healed without 
operative debridement or sldn grafting, although a 
majority of patients with ulceration required some 
local debridement as an outpatient. The wounds 
followed a typical pattern oferythema and induration 
after injection of ethanol, with blister formation and 
skin breakdown occurring in approximately half of 
the wounds. Wound healing time was dependent on 
the size of the initial skin necrosis, but most wounds 
healed within 2 to 3 weeks. Skin necrosis typically 
occurred in the very superficial VM, and the size of 
the ulceration depended on the size of the treated 
VM. Nerve damage, another potential complication 
of ethanol injection, was not seen in the 28 techni- 
cally successful procedures. Patients typically experi- 
enced pain at the injection site for 1 to 2 weeks. 
Focal VMs were treated in a total of seven pa- 
tients, in whom five lesions resolved with a single 
treatment. Four of these patients had previously been 
unsuccessfully treated by a total of 12 surgical exci- 
sions. Another patient who had a buttock and gluteal 
VM required three treatments, which ablated the 
lesion, and his symptoms resolved. These six patients 
were free of symptoms at a mean follow-up of 10 
months. The seventh patient also had a focal VM, 
but the treatment failed because of the inability to 
place the needle into the lesion without extravasation 
of contrast material, and the procedure was aborted. 
Patient number 4 had a VM on the left lateral 
plantar surface of her foot. The lesion was painful, 
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Table I. Summary of study patients 
Patient Number of Follow-up 
age/sex VM location Symptoms Prior treatments treatments Results (mo) 
1. 38/M Thigh, localized Hemorrhage Vein stripping 1 No recurrence of VM 8 
or hemorrhage 
2. 21/F Calf, localized Pain and swelling None 1 No recurrence of 19 
VM, asymptomatic 
3. 28/F Arm, localized Pain and 2 surgical excisions 1 No recurrence of VM 18 
throbbing 
4. 30/F Foot, localized Pain, difficulty 7 surgical excisions 1 VM ablated, 1 
walking asymptomatic 
5. 48/F Popliteal fossa, Pain, swelling, 2 surgical excisions 1 VM ablated, 1 
localized exercise asymptomatic 
limitation 
6. 31/M Buttock and Pain with 1 incisional biopsy 3 No recurrence, 12 
gluteal area, walking and asymptomafic 
localized sitting 
7. 47/F Arm, localized Pain and None Inability to place Technical failure, NA 
weakness needle surgically excised 
without 
extravasation 
Pain and swelling Sclerotherapy, 3 3 with failure to VM decreased in size 29 
surgical cannulate VM after 2 treatments, 
excisions, and 1 on last unable to access 
embolization of treatment VM for further 
feeding veins therapy, patient 
with coils still has symptoms 
Hemorrhage Vein stripping and 2 Hemorrhage in 2 36 
sclerotherapy separate locations 
controlled 
Pain, throbbing, 1 surgical excision 2 Pain resolved in 11 
and numbness treated areas 
8. 41/F 
9. 33/M 
10. 22/M 
tl. 81/F 
Flank and 
paraspinal 
area, 
extensive 
Foot and calf, 
extensive 
Arm, shoulder, 
and chest, 
extensive 
Leg, Klippel- Refractory 
Trenaunay, bleeding after 
extensive placement of 
hip prosthesis 
12. 27/M Both legs, Hemorrhage and 
buttock, pain 
penis, and 
scrotum, 
extensive 
2 hematoma 2 Bleeding resolved 26 
evacuations with after second 
ligation of treatment, 
multiple veins prosthesis removed 
5 months later 
because of 
infection 
None 12 (ongoing) Symptomatic areas 15 
resolved 
and she had difficulties walldng because of pain and 
swelling. She had undergone seven prior attempts at 
surgical excision of the ViM. An arteriogram and a 
venogram (Fig. 1, A and B) of  her foot were normal- 
appearing. MR/ revealed a mass with the typical 
signal intensities of a ViM between the fourth and 
fifth metatarsals in the deep plantar space extending 
into the subcutaneous ti sues with no bony involve- 
ment (Fig. 1, C). The VM was injected with 2 ml of 
absolute thanol, and a follow-up MRI 1 month later 
(Fig. 1, D) revealed a marked decrease in the size of 
the VM with residual soft tissue swelling. The pa- 
tient's symptoms completely resolved. As this case 
demonstrates, MRI or direct injection of contrast 
into the lesions is the preferred imaging method 
because arteriography and venography may not dem- 
onstrate the VM or its true extent. 
Extensive VMs, usually involving an entire ex- 
tremity, were injected for discrete, symptomatic areas 
in four patients, and these treated areas all regressed 
and were asymptomatic. A fifth patient, who had an 
extensive VM of the flank and paraspinal area and 
had undergone multiple attempts at sclerotherapy, 
three surgical excisions, and embolizafion of the ve- 
nous feeding vessels with coils, underwent two suc- 
cessful ethanol treatments, which decreased the size 
of her VM but did not totally alleviate her symp- 
toms. A third treatment was attempted, but access 
by direct injection was unable to be obtained 
and further ethanol treatments could not be per- 
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Fig. 1. Various imaging methods in a patient with VM of the left foot. A, Normal arteriogram; 
B, normal venogram. C, VM between the fourth and fifth metatarsals s a hyperintense (white) 
signal on this T 2 MRI image (arrow). D, T 2 MRI image demonstrates thesame area as C 1 
month after direct injection of ethanol into the lesion (arrow). Notice the greatly decreased size 
of the VM as well as the residual soft tissue swelling from the procedure. 
formed. The five patients had a total of  21 treat- 
ments, and the mean follow-up of these patients 
is 23 months. Ethanol injection was successful in 
palliating these extensive VMs; however, these le- 
sions may require multiple treatments as additional 
areas become problematic. 
Patients 11 and 12 (see Table I) are of particular 
interest and demonstrate he versatility of direct eth- 
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Fig. 2. Venogram demonstrates a large VM from a pa- 
tient with Klippel-Trenaunay s ndrome who experienced 
continued hemorrhage from her incision site after the 
placement of a hip prosthesis. 
anol injection. Patient 11 was a lady who had a right 
hip prosthesis placed at an outside institution and 
experienced continued hemorrhage from her right 
hip incision. She was reexplorcd twice, and a hema- 
toma was evacuated and multiple veins were ligated 
at each operation. She continued to bleed from her 
incision and was transferred for further care. She was 
diagnosed as having Klippel-Trenaunay syndrome 
involving the right leg. Her leg demonstrated the 
characteristic limb enlargement of this syndrome, 
and her venogram (Fig. 2) revealed a large VM with 
absence of the deep venous ystem. An MRI showed 
a huge VM extending from thc right pelvis to the 
distal leg with no evidence of arterial communica- 
tion. Using a combination of ultrasound and direct 
injection of contrast material, eight varicosities were 
localized and sclerosed with ethanol injection. Blood 
continued to ooze from the wound, and the patient 
was again treated 2 days later. This time seven vari- 
cosities were sclcrosed, and her bleeding stopped. 
She had no further trouble with hemorrhage from 
her wound but was readmitted approximately 5 
months later for removal of an infected hip prosthe- 
sis, which was probably a result of her two previous 
Fig. 3. This T 2 MRI study reveals an extensive, superficial 
VM of the right thigh. Notice the hyperintense signal 
(white) of the VM (closed arrow) compared with the signal 
of fat (open arrow). 
operative hematoma evacuations rather than the eth- 
anol injections of the superficial varicosities. The pa- 
tient has had no further problems with hemorrhage 
and is still able to ambulate with a walker despite he 
absence of her right hip joint. 
Patient 12 had an extensive VM of both legs, 
right buttocks, penis, and scrotum. He initially com- 
plained of spontaneous hemorrhage from his right 
medial thigh but has also had difficulty with walking 
and pain. A venogram revealed large, multiple VMs 
with a normal deep venous ystem. An MRI showed 
extensive, superficial VM with no muscular involve- 
ment (Fig. 3). Direct injection ofethanol was used to 
sclerose the bleeding focus, and the patient has had 
no recurrent bleeding from this area. In addition, he 
has had trouble walking and wearing shoes related to 
VM of his feet. Fig. 4 demonstrates direct contrast 
injection into the lesion before (Fig. 4, A) and after 
(B) ethanol sclerosis. To date, this patient has under- 
gone a total of 12 treannents opalliate symptomatic 
areas, including his feet, ankles, buttock, scrotum, 
and penis. 
DISCUSSION 
Direct injection of ethanol into VMs is an effec- 
tive treatment for focal lesions and can provide palli- 
ation of symptomatic areas in extensive l sions. VMs 
of the head and neck have been treated by this 
technique and reported in two different series with 
equally good results. One out of five patients experi- 
enced extensive tissue n crosis after extravasation f
the ethanol and required application of a split-thick- 
ness skin graft in a report by Berthelsen et al. n In a 
JOURNAL OF VASCULAR SURGERY 
Volume 26, Number 5 Shireman et al. 843 
Fig. 4. Extensive VM of the legs that extended onto the right foot is shown with direct 
injection of contrast material (A) and after two injections of ethanol (B). Notice the greatly 
decreased size of the VM after the procedure. 
series reported by Svendsen et al., ~ four of 44 pa- 
tients (9%) had tissue necrosis that required recon- 
structive surgery, and a severe paresis of the facial 
nerve, which resolved spontaneously after 9 months, 
developed in one patient. The patients' blood alco- 
hol levels were measured in this series before and 
after ethanol injection, and only three patients (7%) 
had elevated levels, suggesting that the ethanol was 
contained in a very localized area. Although exten- 
sive tissue necrosis and nerve damage are potential 
complications with this technique, the present series 
did not experience any of these major complications, 
and no extensive operative therapy was needed to 
control wound complications. Blister formation and 
sldn breakdown was a very common occurrence with 
this technique but was easily managed with local 
debridement and wound care in this series. 
Various sclerosing agents have been used other 
than absolute thanol. Richc et al) ° have used direct 
injection of Ethibloc (Ethnor Laboratories, Paris), 
which is a mixture of ethanol, prolamine, amido- 
trizoic acid, and oleum papaveris. After injection, the 
Ethibloc hardens and a mild inflammatory reaction 
ensues. Patients were taken to the operating room 10 
to 12 days after injection, and the lesions were rela- 
tively well delineated and excised with minimal blood 
loss. Six of Riche's patients did not undergo postin- 
jection excision for various reasons. In these patients 
the swelling of the VM improved within 3 weeks of 
the injection, and the lesion continued to contract 
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over the ensuing 2 months. Using absolute ethanol, 
we have not experienced any need for operative xci- 
sion in technically successful procedures. Ethibloc is 
also very viscous, making it more difficult to inject 
than absolute ethanol. 
We have chosen to use absolute ethanol in our 
institution because of  its ability to produce vessel wall 
necrosis 11,12 and believe that it is the most effective 
agent currently available, although there are no ran- 
domized studies that have compared the various 
sclerosing agents. Ethanol is used in many different 
medical applications 1-9,n,12 such as ablation of  renal 
and hepatic tumors, and the use of  ethanol in the 
treatment of  VM is well documented in the litera- 
ture.l-s,ll 
All the patients in this series underwent pretreat- 
ment MRI ,  and several also were followed-up with 
postprocedure MRI.  The VMs all had a characteristic 
appearance on MRI  as previously described, la,14 with 
a decreased signal intensity on the T 1-weighted im- 
age as compared with fat and a hyperintense signal 
intensity on the T2-weighted image. Pathologically, 
these findings have been correlated with the fibro- 
fatty septa between endothelium-lined vascular 
channels. MR1 can distinguish low-flow VMs from 
high-flow arteriovenous malformations and fistulas, 
making arteriograms and venograms unnecessary for 
the evaluation of  most VMs. Early in this series, both 
arteriograms and venograms were routinely ob- 
tained, but currently most patients are initially im- 
aged with MRI  only, which is augmented by direct 
injection of  contrast material into the lesion at the 
time of  ethanol sclerosis. Another advantage of  MRI  
is the delineation of  vascular, neurologic, and muscu- 
lar structures that are adjacent or involved with the 
VM. Other studies, namely venography and arteriog- 
raphy (Fig. 1), do not always show the extent or 
muscular involvement o f  the VM. 
General anesthesia was used for these procedures 
because injection with ethanol is very painful. Manip- 
ulation of  the VM so that the injected ethanol does 
not extravasate or enter normal venous channels can 
be t ime-consuming and is more easily accomplished 
under general anesthesia. It is also important hat the 
patient does not move the treatment area during the 
injection o f  the ethanol. Discomfort after the proce- 
dure was controlled using nonsteroidal pain medica- 
tions, and patients typically reported that the pain 
lasted 2 to 3 weeks. 
CONCLUSION 
Ethanol sclerosis is well tolerated, without sys- 
temic side effects, and is an effective adjunct to the 
management o fVM. Advantages of  ethanol injection 
include the ability to treat a very localized area with- 
out excision as well as the effective treatment o f  VM 
that recurred after operative removal. Conversely, 
extensive lesions may be palliated as symptoms occur. 
We have found MRI  to be the best imaging method 
for the diagnosis and follow-up of  these lesions. 
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